Skip to content
OpenCapital
Get started

Gain Therapeutics GANX Q3 2025 earnings

Reported November 12, 2025 · Before market open

EPS-$0.15In line
EPS estimate-$0.15

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$33.3K
EPS estimate-$0.14

Versus estimates

Diluted EPS

Q1 2026-$0.13In lineQ4 2025-$0.11Beat by $0.03
Q3 2025-$0.15In line
Q2 2025-$0.19Miss by $0.02Q1 2025-$0.16In lineQ4 2024-$0.11Beat by $0.07

Ask the moment Gain Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Gain Therapeutics report Q3 2025 earnings?
Gain Therapeutics (GANX) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Gain Therapeutics's Q3 2025 revenue and EPS?
Gain Therapeutics reported eps of $-0.15 for Q3 2025.
Did Gain Therapeutics beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.15 by $0.00.
How did Gain Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 11.8% from $-0.17.
Where can I find Gain Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-110343) and the 10-Q periodic report (0001104659-25-110347) directly on SEC EDGAR. The filing index links above go to sec.gov.